Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

A Clinical Trial to Assess the Efficacy of a Single-dose of AlphaWave® L-Theanine on Cognitive Function in Healthy Adults With Moderate Stress

Study ID: NCT07004023
Start Date: 2025-10
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

AlphaWave® L-Theanine

Placebo

Sponsor

Ethical Naturals, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma

Study ID: NCT06418724
Start Date: 2025-12-11
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

27

Intervention / Treatment

Cetuximab

Cemiplimab

Sponsor

Melanoma and Skin Cancer Trials Limited

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease

Study ID: NCT07138196
Start Date: 2025-11-17
End Date: 2029-10-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

Enrichet

Sponsor

Qurient Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Metabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET

Study ID: NCT07100470
Start Date: 2025-10-01
End Date: 2029-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

55

Intervention / Treatment

Sodium MRI

Sponsor

St Anne hospital center

Source: clinicaltrials.gov

Share:
Add to list

Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: an Efficacy Study

Study ID: NCT04387305
Start Date: 2025-10-01
End Date: 2030-03-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

2000

Intervention / Treatment

Tranexamic acid injection

Sponsor

Daniel Nishijima, MD, Mas

Source: clinicaltrials.gov

Share:
Add to list

An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa

Study ID: NCT06518941
Start Date: 2026-06
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

10

Intervention / Treatment

Donepezil

Sponsor

New York State Psychiatric Institute

Source: clinicaltrials.gov

Share:
Add to list

Window Prophylaxis for Pediatric Tuberculosis Prevention Trial

Study ID: NCT07086820
Start Date: 2025-10
End Date: 2028-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

647

Intervention / Treatment

Tuberculosis window prophylaxis with weekly rifapentine and isoniazid for 12 weeks

Standard of care tuberculosis prophylaxis with weekly rifapentine and isoniazid for 12 weeks

Sponsor

Pontifical Catholic University of Chile

Source: clinicaltrials.gov

Share:
Add to list

PS-002 for the Treatment of IgA Nephropathy in Adults

Study ID: NCT07182227
Start Date: 2025-10
End Date: 2029-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

32

Intervention / Treatment

PS-002

Sponsor

Purespring Therapeutics Limited

Source: clinicaltrials.gov

Share:
Add to list

iHub Stent-Graft for Iliac Artery Aneurysms: Safety, Performance, and Effectiveness Study

Study ID: NCT07005141
Start Date: 2025-11-01
End Date: 2028-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Endovascular Iliac Branch Stent-Graft Implantation

Sponsor

Medical Arch S.A

Source: clinicaltrials.gov

Share:
Add to list

Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza

Study ID: NCT07095257
Start Date: 2025-10-20
End Date: 2026-04-15
Study Type

Interventional

Study Phase

Phase3

No. of Participants

168

Intervention / Treatment

ZX-7101A for oral suspension

Oseltamivir phosphate for oral suspension

Sponsor

Nanjing Zenshine Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list